Every AI newsletterbuffalorisingmegawaysonline, some investors asked questions on the investor interactive platform: Hello Secretary Dong! May I ask if your company's atropine (Meiou product) is currently on the marketbuffalorisingmegawaysonline, there are 70 million young myopia patients across the country. Can the company's current production capacity keep up? Whether atropine has a chance to get medical insurance this year. Thank you!
Xingqi Eye Medicine (300573buffalorisingmegawaysonline.SZ) stated on the investor interaction platform on May 14 that the company's production capacity can currently meet market demand. Regarding whether atropine will enter medical insurance, the company will make appropriate decisions based on market conditions.
(Reporter Bi Luming)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Verification before use. Operate accordingly and bear the risks at your own expense.
daily economic news
